# US 2025/0084392 A1 · Strategies for direct recruitment of repair templates to crispr nucleases

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0084392 A1
- Document ID: US20250084392A1
- Status: Published application
- Kind: A1
- Application number: 18/725,912
- Filed: 2023-01-04
- Published: 2025-03-13
- Earliest claimed: 2022-01-04
- Assignees: Inscripta, Inc.
- Applicants: Inscripta, Inc.
- Inventors: Brian Chaikind; Christopher Lim
- Web page: https://patentgrep.com/patent/US20250084392A1

## CPC

- C12N 9/226: {Class 2 CAS enzyme complex, e.g. single CAS protein}
- C12N 9/22: Ribonucleases {[RNase]; Deoxyribonucleases [DNase]}
- C12N 15/111: {General methods applicable to biologically active non-coding nucleic acids}
- C12N 15/907: {in mammalian cells}
- C07K 2319/20: containing a tag with affinity for a non-protein ligand
- C12N 2310/20: involving clustered regularly interspaced short palindromic repeats [CRISPR]
- Y02A 50/30: Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- Y02A: TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE

## Abstract

This invention relates to compositions of matter, methods and instruments for directly recruiting repair templates to CRISPR nucleases to stimulate homology-directed repair. Molecular “tethers” are described which result in an increase in the local concentration of repair templates at the site of the double-strand break made by a nuclease, thereby enhancing the rate of homology directed repair and suppressing undesired edits.

## Claims

### Claim 1

A system comprising: (i) a fusion polypeptide comprising first and second orthogonal nucleases and further comprising or coupled to a recruiting moiety, (ii) a repair template comprising or coupled with a binding moiety, and optionally (iii) one or more guide RNAs; wherein the recruiting moiety recognizes the binding moiety and forms a binding pair.

### Claim 2 (depends on 1)

The system of claim 1, wherein the system performs genome repair via homology directed repair (HDR).

### Claim 3 (depends on 1)

The system of claim 1, wherein one or both of the first and second orthogonal nucleases is an RNA-guided nuclease.

### Claim 4 (depends on 1)

The system of claim 1, wherein one or both of the first and second orthogonal nucleases is a CRISPR nuclease.

### Claim 5 (depends on 1)

The system of claim 1, wherein the recruiting moiety is streptavidin and the binding moiety is biotin or wherein the recruiting moiety is biotin and the binding moiety is streptavidin.

### Claim 6 (depends on 1)

The system of claim 1, wherein the recruiting moiety is Epstein-Barr virus (EBV)-encoded nuclear antigen-1 (EBNA1) and the binding moiety is an origin of plasmid replication (oriP) or wherein the recruiting moiety is oriP and the binding moiety is EBNA1.

### Claim 7 (depends on 1)

The system of claim 1, wherein the recruiting moiety is SV40 T-antigen and the binding moiety is SV40 origin of replication or wherein the recruiting moiety is SV40 origin of replication and the binding moiety is SV40 T-antigen.

### Claim 8 (depends on 1)

The system of claim 1, wherein the recruiting moiety is BK T-antigen and the binding moiety is BK Virus (BKV) origin of replication or wherein the recruiting moiety is BKV origin of replication and the binding moiety is BK T-antigen.

### Claim 9 (depends on 1)

The system of claim 1, wherein the recruiting moiety is latency-associated nuclear antigen (LANA1) of Karposi's Sarcoma Herpesvirus (KSHV) and the binding moiety is LANA binding site (LBS) of KSHV or wherein the recruiting moiety is LANA binding site of KSHV and the binding moiety is LANA1 of KSHV.

### Claim 10 (depends on 1)

The system of claim 1, wherein the recruiting moiety is E2 protein of human papilloma virus (HPV) and the binding moiety is minichromosome maintenance element (MME) region of HPV or wherein the recruiting moiety is MME region of HPV and the binding moiety is E2 protein of HPV.

### Claim 11 (depends on 1)

The system of claim 1, wherein the recruiting moiety is an HUH-tag and the binding moiety is an HUH recognition sequence or wherein the recruiting moiety is an HUH recognition sequence and the binding moiety is an HUH-tag.

### Claim 12 (depends on 1)

The system of claim 1, wherein the recruiting moiety is a Udg variant and the binding moiety is uracilated DNA or wherein the recruiting moiety is uracilated DNA and the binding moiety is a Udg variant.

### Claim 13 (depends on 1)

The system of claim 1, wherein the recruiting moiety is a retron and the binding moiety is retron-synthesized RNA.

### Claim 14 (depends on 1)

The system of claim 1, wherein the one or more guide RNAs comprise a G-quadruplex (GQ)-forming sequence, wherein the repair template further comprises a corresponding GQ-forming sequence, and wherein the one or more guide RNAs is non-covalently linked to the repair template by formation of a GQ.

### Claim 15 (depends on 1)

The system of claim 1, wherein the one or more guide RNAs comprise a heteroduplex barcode sequence, wherein the repair template further comprises the reverse complement of the heteroduplex barcode sequence, and wherein the one or more guide RNA is non-covalently linked to the repair template by formation of a RNA/DNA hybrid.

### Claim 16

A system comprising: (i) an RNA-guided nuclease, (ii) a guide RNA comprising or coupled to a recruiting moiety, and (iii) a repair template molecule comprising or coupled with a binding moiety; wherein the recruiting moiety recognizes the binding moiety and forms a binding pair.

### Claim 17 (depends on 16)

The system of claim 16, wherein the recruiting moiety comprises a G-quadruplex (GQ)-forming sequence.

### Claim 18 (depends on 17)

The system of claim 17, wherein the binding moiety comprises a corresponding G-quadruplex (GQ)-forming sequence.

### Claim 19 (depends on 16)

The system of claim 16, wherein the recruiting moiety comprises a heteroduplex barcode sequence.

### Claim 20 (depends on 19)

The system of claim 19, wherein the binding moiety comprises a reverse complement of the heteroduplex barcode sequence.
